ARV is a drug that is usually taken to prevent the spread of HIV in the blood. ARVs help reduce the amount of HIV in the blood.
However, swallowing ARV every day can be exhausting. No one likes to take medication every day. This is why many people have to take their ARV medication by default. Doreen Muracha, a leading HIV leader in Kenya, who was recently appointed to represent HIV control in Kenya, Tanzania, and Uganda, described her experience with ARVS.
Doreen revealed that she was worried that people would judge her. Doreen even said that she stopped taking ARVS at some point. Anyway, Doreen revealed that she had started to get very sick very often. Doreen revealed that she has had several potential infections, including herpes zoster.
Doreen no longer finds that living a healthy life is important. So Doreen came home and resumed her meal. This is why Doreen is proud to show the public her ARV medicine. See post-Doreens below.
Content created and supplied by: Val_Wambo (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More